SJD Consulting LLC, Ijamsville, MD, USA.
Inotiv, Inc., RTP, NC, USA.
ALTEX. 2024;41(3):402-424. doi: 10.14573/altex.2403261. Epub 2024 May 15.
The webinar series and workshop titled “Trust Your Gut: Establishing Confidence in Gastrointestinal Models – An Overview of the State of the Science and Contexts of Use” was co-organized by NICEATM, NIEHS, FDA, EPA, CPSC, DoD, and the Johns Hopkins Center for Alternatives to Animal Testing (CAAT) and hosted at the National Institutes of Health in Bethesda, MD, USA on October 11-12, 2023. New approach methods (NAMs) for assessing issues of gastrointestinal tract (GIT)- related toxicity offer promise in addressing some of the limitations associated with animal-based assessments. GIT NAMs vary in complexity, from two-dimensional monolayer cell line-based systems to sophisticated 3-dimensional organoid systems derived from human primary cells. Despite advances in GIT NAMs, challenges remain in fully replicating the complex interactions and processes occurring within the human GIT. Presentations and discussions addressed regulatory needs, challenges, and innovations in incorporating NAMs into risk assessment frameworks; explored the state of the science in using NAMs for evaluating systemic toxicity, understanding absorption and pharmacokinetics, evaluating GIT toxicity, and assessing potential allergenicity; and discussed strengths, limitations, and data gaps of GIT NAMs as well as steps needed to establish confidence in these models for use in the regulatory setting.
本次网络研讨会系列和研讨会的标题为“相信你的直觉:在胃肠道模型中建立信心——科学现状和使用背景概述”,由 NICEATM、NIEHS、FDA、EPA、CPSC、DoD 和约翰霍普金斯替代动物测试中心(CAAT)共同组织,并于 2023 年 10 月 11 日至 12 日在美国马里兰州贝塞斯达的美国国立卫生研究院举行。用于评估胃肠道(GIT)相关毒性问题的新方法(NAMs)在解决与基于动物的评估相关的一些限制方面具有很大的应用前景。GIT NAMs 的复杂性各不相同,从二维单层细胞系系统到源自人类原代细胞的复杂 3 维类器官系统。尽管 GIT NAMs 取得了进展,但在完全复制人类 GIT 内发生的复杂相互作用和过程方面仍存在挑战。演讲和讨论涉及将 NAMs 纳入风险评估框架的监管需求、挑战和创新;探讨了使用 NAMs 评估系统毒性、了解吸收和药代动力学、评估 GIT 毒性以及评估潜在致敏性的科学现状;并讨论了 GIT NAMs 的优势、局限性和数据差距,以及在监管环境中使用这些模型建立信心所需的步骤。